3d
HealthDay on MSNStudy Identifies Some Modifiable Risk Factors for Ovarian CancerSome risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the I ...
The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...
It usually arises from benign serous tumours. There are also several less common subtypes including, but not limited to, mucinous ovarian cancer, endometrioid ovarian cancer, transitional cell ...
endometrioid adenocarcinoma of the fallopian tube. This patient had a strong family history of breast and ovarian cancers, and genetic study suggested a lifetime risk of breast cancer of about 80% ...
Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...
Patients with relapsed ovarian cancer who had germline or somatic BRCA mutations saw greater OS with olaparib, according to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results